RxDoctor Payments Data

Kisseng Hsieh

Urology · Pleasanton, CANPI 1053300236

Payments from drug & device makers

$1,743in general payments, 2019–2025

Across 63 payments — averaging $27.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teleflex LLC$229
  • Johnson & Johnson$153
  • Procept Biorobotics Corporation$136
  • Immunitybio, Inc.$117
  • Sumitomo Pharma America, Inc.$102
  • Boston Scientific$94
  • plus $912 from 28 others

What the payments were for

  • Food & beverage$1,64794%
  • Education$966%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,743 in reported general payments places this provider in the 40th percentile of 1,324 urology providers in California.

See all urology providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron77$75,095
GemtesaVibegron19$18,138
Tamsulosin Hcl651$10,942
Finasteride460$7,818
Silodosin78$6,223
Dutasteride86$4,849
Potassium Citrate ErPotassium Citrate18$2,705
Oxybutynin Chloride ErOxybutynin Chloride91$2,255
Methenamine Hippurate32$1,921
Alfuzosin Hcl ErAlfuzosin Hcl45$963
Ciprofloxacin Hcl108$501
Bicalutamide25$480
Solifenacin Succinate14$345
Oxybutynin Chloride12$300
Ampicillin Trihydrate29$241

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$56$75,09577 claims
Sumitomo Pharma America, Inc.Gemtesa$102$18,13819 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 1,324 urology providers in California.

Other urology in Pleasanton

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →